| scholarly article | Q13442814 |
| P50 | author | Allan Flyvbjerg | Q49252518 |
| Helge Røsjø | Q63986072 | ||
| Torbjørn Omland | Q65675689 | ||
| P2093 | author name string | Kenneth Caidahl | |
| Marianne Hartford | |||
| Thomas Karlsson | |||
| Anna M Jansson | |||
| P2860 | cites work | Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction | Q22242900 |
| The chromogranin-secretogranin family | Q28185052 | ||
| Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes | Q28306261 | ||
| Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
| Microglial secreted cathepsin B induces neuronal apoptosis. | Q32134547 | ||
| Secretion from chromaffin cells is controlled by chromogranin A-derived peptides | Q33558750 | ||
| Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog | Q33865893 | ||
| Marked increase in gastric acid secretory capacity after omeprazole treatment | Q34410460 | ||
| Regulation of endothelial cell shape and barrier function by chromogranin A. | Q35001484 | ||
| Chromogranin A-activated microglial cells induce neuronal apoptosis | Q35001557 | ||
| Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population | Q36762703 | ||
| Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist | Q37372768 | ||
| Plasma chromogranin A as a marker of sympathochromaffin activity in humans | Q41178510 | ||
| Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A. | Q41446223 | ||
| Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart | Q42443883 | ||
| Chromogranin A correlates with norepinephrine release rate | Q43453270 | ||
| Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure | Q43632766 | ||
| Relationship between renal function and blood level of chromogranin A. | Q43703519 | ||
| Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. | Q44031331 | ||
| Association between plasma chromogranin A concentration and long-term mortality after myocardial infarction | Q44395974 | ||
| N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes | Q44446907 | ||
| Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy | Q44522432 | ||
| Is physiologic sympathoadrenal catecholamine release exocytotic in humans? | Q45933777 | ||
| Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function | Q48227087 | ||
| The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels | Q67596111 | ||
| Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart | Q68417013 | ||
| Chromogranins--new sensitive markers for neuroendocrine tumors | Q69351778 | ||
| Secretion of chromogranin A by peptide-producing endocrine neoplasms | Q70135399 | ||
| Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma | Q70596778 | ||
| A comparison between three commercial kits for chromogranin A measurements | Q73375838 | ||
| Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage | Q75303240 | ||
| New concept in echocardiography: harmonic imaging of tissue without use of contrast agent | Q77464024 | ||
| Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction | Q79310859 | ||
| Spectrum of acute coronary syndromes: history and clinical presentation in relation to sex and age | Q79971616 | ||
| P433 | issue | 1 | |
| P921 | main subject | acute coronary syndrome | Q266018 |
| P304 | page(s) | 25-32 | |
| P577 | publication date | 2008-11-21 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Prognostic value of circulating chromogranin A levels in acute coronary syndromes | |
| P478 | volume | 30 |
| Q42511816 | A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders |
| Q35167066 | A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K-eNOS pathway in the myocardium |
| Q33574106 | Biological function and clinical relevance of chromogranin A and derived peptides |
| Q40690975 | Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway |
| Q34435168 | Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart. |
| Q39210583 | Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling. |
| Q33838302 | Catestatin: a multifunctional peptide from chromogranin A |
| Q36582343 | Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls |
| Q90541320 | Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation |
| Q38170143 | Chromogranin A as a biomarker in cardiovascular disease |
| Q64911918 | Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma. |
| Q48728926 | Chromogranin A in the mammalian heart: expression without secretion |
| Q56373623 | Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors |
| Q37639931 | Chromogranin A: a novel susceptibility gene for essential hypertension |
| Q38258283 | Chromogranin A: a paradoxical player in angiogenesis and vascular biology |
| Q45341440 | Chromogranin location in the adrenal glands of ISIAH rats |
| Q34376655 | Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga364–384) |
| Q47668183 | Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers. |
| Q35303917 | Correlation of plasma catestatin level and the prognosis of patients with acute myocardial infarction |
| Q34235022 | Genes involved in systemic and arterial bed dependent atherosclerosis--Tampere Vascular study |
| Q47702359 | Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure |
| Q34388245 | Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heart |
| Q54549853 | Increased N-terminal CgA in circulation associated with cardiac reperfusion in pigs. |
| Q38195423 | Making sense of chromogranin A in heart disease |
| Q57495851 | Neuroendocrine System Regulatory Mechanisms: Acute Coronary Syndrome and Stress Hyperglycaemia |
| Q64056872 | Neutrophil count as the centerpiece in the joined association networks of inflammatory and cell damage markers, and neuroendocrine stress markers in patients with stable angina pectoris following stenting |
| Q37890908 | Novel biomarkers in acute heart failure |
| Q39397373 | Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease |
| Q38361700 | Plasma chromogranin A is a marker of death in elderly patients presenting with symptoms of heart failure |
| Q43442071 | Plasma levels and potential roles of catestatin in patients with coronary heart disease |
| Q33554096 | Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial |
| Q34227666 | Prognostic value of chromogranin A in severe sepsis: data from the FINNSEPSIS study |
| Q42944201 | Prognostic value of circulating chromogranin A levels in acute coronary syndrome. |
| Q37802015 | Reprint of: Catestatin: A multifunctional peptide from chromogranin A |
| Q43635219 | Salivary chromogranin A, but not α-amylase, correlates with cardiovascular parameters during high-intensity exercise. |
| Q27302632 | Secretogranin II; a protein increased in the myocardium and circulation in heart failure with cardioprotective properties |
| Q93025370 | Stress, Well-Being and Reproductive Success |
| Q36666413 | The extended granin family: structure, function, and biomedical implications |
| Q28579371 | The novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β-adrenergic-like inotropes |
| Q38245248 | The surging role of Chromogranin A in cardiovascular homeostasis |
| Q83179013 | [Ischemic heart disease: 2009 update] |
| Q92960094 | iTRAQ‑based quantitative proteomics analysis of the potential application of secretoneurin gene therapy for cardiac hypertrophy induced by DL‑isoproterenol hydrochloride in mice |
Search more.